UT Austin’s RiboNN AI Speeds mRNA-Based Therapy Development

UT Austin’s RiboNN AI Speeds mRNA-Based Therapy Development

Revolutionizing mRNA Therapeutics In a groundbreaking advancement that could reshape the future of medicine, researchers have unveiled an artificial intelligence model capable of predicting protein production from mRNA sequences with unprecedented accuracy. This innovation, detailed in a recent study from The University of Texas at Austin, promises to accelerate the development of vaccines and therapies for diseases ranging from cancer to geneti…

AI breakthrough predicts how mRNA makes proteins inside the body

In the fast-evolving field of medical science, a new artificial intelligence model may be about to change the way mRNA-based drugs and vaccines are designed. Developed through a collaboration between the University of Texas at Austin and pharmaceutical company Sanofi, the tool could help researchers predict how efficiently different mRNA sequences will produce proteins inside the body. That ability could significantly reduce trial-and-error in d…